Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis
2011

Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis

Sample size: 73 publication Evidence: moderate

Author Information

Author(s): Fernando Sumadhya Deepika, Rodrigo Chaturaka, Rajapakse Senaka

Primary Institution: University of Colombo, Colombo, Sri Lanka

Conclusion

The review summarizes the efficacy of various antifilarial agents in treating bancroftian filariasis, highlighting the effectiveness of diethylcarbamazine and combination therapies.

Supporting Evidence

  • Diethylcarbamazine (DEC) is the main drug used for treating bancroftian filariasis.
  • Ivermectin is effective but has limited macrofilaricidal effects.
  • Combination therapies show better long-term outcomes than single drug treatments.
  • Doxycycline can reduce microfilaria rates and adult worm activity.

Takeaway

This study looks at different medicines used to treat a disease caused by tiny worms in the body, showing which ones work best.

Methodology

The authors conducted a MEDLINE search for articles on Wuchereria bancrofti published in English from 1999 to 2009, reviewing 73 relevant papers.

Limitations

The review was limited to articles published in English within a specific time frame, potentially missing important studies in other languages.

Digital Object Identifier (DOI)

10.1155/2011/175941

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication